Empagliflozin and linagliptin and Mogamulizumab-kpkc Intravenous
Determining the interaction of Empagliflozin and linagliptin and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / linagliptin
Brand name: Glyxambi
Synonyms: Empagliflozin and Linagliptin
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and linagliptin-Molindone
- Empagliflozin and linagliptin-Mometasone (Oral Inhalation)
- Empagliflozin and linagliptin-Mometasone and Formoterol
- Empagliflozin and linagliptin-Mometasone and formoterol Inhalation
- Empagliflozin and linagliptin-Mometasone Cream
- Empagliflozin and linagliptin-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Empagliflozin and metformin
- Mogamulizumab-kpkc Intravenous-Empagliflozin and Metformin Extended-Release Tablets
- Mogamulizumab-kpkc Intravenous-Empagliflozin and Metformin Tablets
- Mogamulizumab-kpkc Intravenous-Empliciti
- Mogamulizumab-kpkc Intravenous-Emsam
- Mogamulizumab-kpkc Intravenous-Emsam Transdermal